193
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Mortality Predictors Among COVID-19 Elderly in Taif, Saudi Arabia

, , , , , , , & ORCID Icon show all
Pages 3213-3223 | Published online: 20 Jun 2022

References

  • University JH. COVID 19 map; 2021. Available from: https://coronavirus.jhu.edu/region/saudi-arabia. Accessed December 25, 2021.
  • University JH. COVID 19 in Saudi; 2021. Available from: https://coronavirus.jhu.edu/map.html. Accessed December 25, 2021.
  • Khan A, Alsofayan Y, Alahmari A, Alowais J, Algwizani A, Alserehi H. COVID-19 in Saudi Arabia: the national health response. East Mediterr Health J. 2021;27:1114–1124. doi:10.26719/emhj.21.048
  • Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242. doi:10.1001/jama.2020.2648
  • Wong SH, Lui RN, Sung JJ. Covid‐19 and the digestive system. J Gastroenterol Hepatol. 2020;35(5):744–748. doi:10.1111/jgh.15047
  • Allotey J, Stallings E, Bonet M, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320. doi:10.1136/bmj.m3320
  • Henderson LA, Canna SW, Schulert GS, et al. On the Alert for cytokine storm: immunopathology in COVID −19. Arthritis Rheumatol. 2020;72:1059–1063. doi:10.1002/art.41285
  • Mahmudpour M, Roozbeh J, Keshavarz M, Farrokhi S, Nabipour I. COVID-19 cytokine storm: the anger of inflammation. Cytokine. 2020;133:155151. doi:10.1016/j.cyto.2020.155151
  • Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
  • Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39:529–539. doi:10.1007/s00281-017-0629-x
  • Richards M, DeBonis K. Psychiatric training during a global pandemic: how COVID-19 has affected clinical care, teaching, and trainee well-being. Psychiatr Serv. 2020;71(12):1300–1302. doi:10.1176/appi.ps.202000277
  • Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422. doi:10.1016/S2213-2600(20)30076-X
  • Morris DE, Cleary DW, Clarke SC. Secondary bacterial infections Associated with Influenza Pandemics. Front Microbiol. 2017;8:1041. doi:10.3389/fmicb.2017.01041
  • Cox MJ, Loman N, Bogaert D, O’grady J. Co-infections: potentially lethal and unexplored in COVID-19. Lancet Microbe. 2020;1(1):e11. doi:10.1016/S2666-5247(20)30009-4
  • Hashemi SA, Safamanesh S, Ghafouri M, Taghavi MR. Co-infection with COVID-19 and influenza A virus in two died patients with acute respiratory syndrome, Bojnurd, Iran. J Med Virol. 2020;92:2319–2321. doi:10.1002/jmv.26014
  • Griffin DO, Brennan-Rieder D, Ngo B, et al. The importance of understanding the stages of COVID-19 in treatment and trials. AIDS Rev. 2021;23. doi:10.24875/AIDSRev.200001261
  • Real-time-meta-analysis. COVID-19 early treatment: real-time analysis of 749 studies: unknown; 2021 Available from: https://c19early.com/. Accessed June 13, 2022.
  • Ahmad Malik J, Ahmed S, Shinde M, et al. The impact of COVID-19 on comorbidities: a review of recent updates for combating it. Saudi J Biol Sci. 2022;29(5):3586–3599. PMID: 35165505; PMCID: PMC8828435. doi:10.1016/j.sjbs.2022.02.006
  • Yan Y, Pang Y, Lyu Z, et al. The COVID-19 vaccines: recent development, challenges and prospects. Vaccines. 2021;9(4):349. doi:10.3390/vaccines9040349
  • Montastruc J-L, Lafaurie M, de Canecaude C, et al. COVID-19 vaccines: a perspective from social pharmacology. Therapies. 2021;76:311–315. doi:10.1016/j.therap.2021.05.010
  • Food, Administration D. COVID-19 vaccines authorized for emergency use; 2021.
  • Salluh JI, Lisboa T, Bozza FA. Challenges for the care delivery for critically ill COVID-19 patients in developing countries: the Brazilian perspective. Crit Care. 2020;24(1):1–3. doi:10.1186/s13054-020-03278-7
  • Cénat JM. The vulnerability of low-and middle-income countries facing the COVID-19 pandemic: the case of Haiti. Travel Med Infect Dis. 2020;37:101684. doi:10.1016/j.tmaid.2020.101684
  • Available from: https://www.surveysystem.com/sscalc.htm. Accessed June 13, 2022.
  • Macedo A, Gonçalves N, Febra C. COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis. Ann Epidemiol. 2021;57:14–21. doi:10.1016/j.annepidem.2021.02.012
  • Nguyen NT, Chinn J, De Ferrante M, Kirby KA, Hohmann SF, Amin A. Male gender is a predictor of higher mortality in hospitalized adults with COVID-19. PLoS One. 2021;16(7):e0254066. doi:10.1371/journal.pone.0254066
  • Alguwaihes AM, Al-Sofiani ME, Megdad M, et al. Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study. Cardiovasc Diabetol. 2020;19:205. doi:10.1186/s12933-020-01184-4
  • Jin JM, Bai P, He W, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152. doi:10.3389/fpubh.2020.00152
  • Galbadage T, Peterson BM, Awada J, et al. Systematic review and meta-analysis of sex-specific COVID-19 clinical outcomes. Front Med. 2020;7:348. doi:10.3389/fmed.2020.00348
  • Strope JD, Chau CH, Figg WD. Are sex discordant outcomes in COVID-19 related to sex hormones? Semin Oncol. 2020;S0093–7754(20):30062. doi:10.1053/j.seminoncol.2020.06.002
  • Ortona E, Pierdominici M, Rider V. Editorial: sex hormones and gender differences in immune responses. Front Immunol. 2019;10:1076. doi:10.3389/fimmu.2019.01076
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. PMID: 32171076; PMCID: PMC7270627. doi:10.1016/S0140-6736(20)30566-3
  • Al-Ansari RY, Alshaer A, Al-Anazi A, et al. ABO in correlation to the requirement of mechanical ventilation and mortality in critically Ill patients with COVID-19. J Hematol. 2021;10(2):64–70. doi:10.14740/jh821
  • American Dental Association. How coronavirus impacts people with diabetes; 2021. Available from: https://www.diabetes.org/coronavirus-covid-19/how-coronavirus-impacts-people-with-diabetes. Accessed June 13, 2022.
  • Mubarik S, Liu X, Eshak ES, et al. The Association of Hypertension With the Severity of and Mortality From the COVID-19 in the Early Stage of the Epidemic in Wuhan, China: a Multicenter Retrospective Cohort Study. Front Med. 2021;8:631.
  • O’Leary L, Hughes-McCormack L, Dunn K, Cooper SA. Early death and causes of death of people with down syndrome: a systematic review. J Appl Res Intellect Disabil. 2018;31(5):687–708. doi:10.1111/jar.12446
  • Al Mutair A, Al Mutairi A, Zaidi ARZ, et al. Clinical predictors of COVID-19 mortality among patients in intensive care units: a retrospective study. Int J Gen Med. 2021;14:3719–3728. doi:10.2147/IJGM.S313757
  • Kurtz P, Bastos LSL, Dantas LF, et al. Evolving changes in mortality of 13,301 critically ill adult patients with COVID-19 over 8 months. Intensive Care Med. 2021;47(5):538–548. doi:10.1007/s00134-021-06388-0
  • Borghesi A, Zigliani A, Golemi S, et al. Chest X-ray severity index as a predictor of in-hospital mortality in coronavirus disease 2019: a study of 302 patients from Italy. Int J Infect Dis. 2020;96:291–293. doi:10.1016/j.ijid.2020.05.021
  • Chiwhane A, Diwan S. Characteristics, outcome of patients on invasive mechanical ventilation: a single center experience from central India. J Crit Care Med. 2016;4(3):113–118. doi:10.1016/j.ejccm.2016.10.003
  • Schönhofer B, Euteneuer S, Nava S, Suchi S, Köhler D. Survival of mechanically ventilated patients admitted to a specialised weaning centre. Intensive Care Med. 2002;28(7):908–916. PMID: 12122529. doi:10.1007/s00134-002-1287-5